Williams Hants, Tanabe Paula
School of Nursing, Duke University, Durham, North Carolina, USA.
School of Nursing, Duke University, Durham, North Carolina, USA; School of Medicine, Duke University, Durham, North Carolina, USA.
J Pain Symptom Manage. 2016 Feb;51(2):163-77. doi: 10.1016/j.jpainsymman.2015.10.017. Epub 2015 Nov 17.
Sickle cell disease (SCD) is a life-threatening condition that affects more than seven million people worldwide. The most common complication experienced by persons living with SCD is pain. Evidence supports the use of nonpharmacologic therapies in managing psychological and social complications of pain in persons with SCD, but there is little consensus if these approaches can also be applied for the treatment of pain in SCD.
To describe and synthesize the use of nonpharmacological therapies for reducing pain of any type and origin in persons with SCD.
A literature search was conducted using PsycINFO, PsycARTICLES, PubMed, CINAHL, and Embase. Databases were searched using the following terms: sickle cell, pain, and nonpharmacological therapies. Interventions were graded for methodological quality and categorized as 1) peer-support group therapies, 2) educational/psychological therapies, and 3) skill-based therapies.
Twenty-eight nonpharmacological interventions for persons with SCD were examined. Of these studies, a wide variety of nonpharmacological interventions were tested. Twelve studies yielded significant improvements in pain, three studies reported no positive effect or differences between experimental and control conditions on pain or a pain-related outcome, and one study reported a negative or detrimental intervention effect.
Approximately half of the studies reviewed demonstrated success in alleviating pain, suggesting that patients are able to use nonpharmacological interventions to reduce pain with some degree of success. Questions still remain regarding the efficacy and generalizability of these interventions for persons with SCD.
镰状细胞病(SCD)是一种危及生命的疾病,全球有超过700万人受其影响。SCD患者最常见的并发症是疼痛。有证据支持使用非药物疗法来管理SCD患者疼痛的心理和社会并发症,但对于这些方法是否也可用于治疗SCD患者的疼痛,目前几乎没有共识。
描述并综合使用非药物疗法减轻SCD患者任何类型和来源的疼痛。
使用PsycINFO、PsycARTICLES、PubMed、CINAHL和Embase进行文献检索。使用以下术语搜索数据库:镰状细胞、疼痛和非药物疗法。对干预措施的方法学质量进行分级,并分为1)同伴支持小组疗法,2)教育/心理疗法,以及3)基于技能的疗法。
对28项针对SCD患者的非药物干预措施进行了研究。在这些研究中,测试了各种各样的非药物干预措施。12项研究显示疼痛有显著改善,3项研究报告在疼痛或与疼痛相关结果方面,实验条件与对照条件之间没有积极效果或差异,1项研究报告了负面或有害的干预效果。
大约一半的综述研究表明在减轻疼痛方面取得了成功,这表明患者能够使用非药物干预措施在一定程度上成功减轻疼痛。关于这些干预措施对SCD患者的疗效和普遍性,仍然存在问题。